Author: Elizabeth Aragao

Acquisition supports Black Diamond’s commitment to best-in-class project management and staffing services to federal agencies, highly-regulated industries, and beyond.
Black Diamond Networks (“BDN”) announced it has acquired Ascension Global Solutions, LLC (“AGS”), a Massachusetts-based organization focused on lifecycle acquisition support solutions for the Department of Defense (DoD) and Federal...
Black Diamond Project Solutions
How do new drugs in development get through development? Oftentimes, it’s due to a strong partnership with a clinical research organization (CRO). And who do the CROs partner with when they need expert help? Black Diamond Networks.
Meet Bret Cerasoli, the new president of Black Diamond Networks
A supremely gifted recruiter, Cerasoli worked his way up from the desk level and forged his own path. Earlier this year he became the second president in Black Diamond's history.
Tracking the volume and velocity of drug trends
We take a look at why and how drug trends unfold to help predict regulatory shifts and prepare for resource gaps before they happen.
A Signal of The Future of Pharma and Med Device
President Biden has recently nominated Robert Califf to be the Commissioner of The US Food and Drug Administration. What changes will this bring to the FDA and across pharma and medtech industries. Ben Locwin discusses in his latest blog post.
The numbers, the science, and reasons for hope
We all, with certainty, have known or will know someone suffering from Alzheimer’s Disease. Black Diamond's Ben Locwin looks at the science, research, treatment, and reasons to hope when it comes to Alzheimer's.
A conversation with Ryan Mahan, Director of Talent Acquisition at Black Diamond Networks
From one championship team to the next, Ryan Mahan, Black Diamond's Director of Talent Acquisition, weighs in on quantifying grit.
"It’s hard to say that anyone really has equity if not everyone has equity"
Looking at risk, growth, and equity in the aftermath of a global pandemic. Black Diamond Networks' Ben Locwin considers where we are heading.
What it means and how it's changing in a COVID world
With vaccine development suddenly in the spotlight due to the global pandemic, pharmacovigilance will be under even more scrutiny. BDN's Ben Locwin explains.
A conversation with Ben Locwin
Meet Ben Locwin, a Life Sciences subject matter expert with Black Diamond Networks, supporting our clients in Project Solutions and beyond. We talk about public health, the pandemic, vaccines, and more.